PLBY Group, Inc. — Form 8-K Summary
Reporting date: August 9, 2021; the filing was signed August 11, 2021. The report covers the completion of PLBY Group’s acquisition of Honey Birdette (Aust) Pty Limited (“Honey Birdette”), an Australian lingerie and retail business. The filing does not provide a quarterly or annual income statement, balance sheet, or cash-flow period.
Transaction and Key Financial Terms
- PLBY acquired all outstanding shares of Honey Birdette, making it an indirect, wholly owned subsidiary.
- Total consideration was approximately AUD443 million, or approximately US$328 million based on the August 6, 2021 exchange rate.
- Consideration included approximately AUD318 million (US$235 million) in cash and 2,155,849 PLBY common shares valued at approximately AUD125 million (US$93 million), based on an issue price of $43.0155 per share.
- Approximately AUD1 million, or US$739,100, was placed in escrow for certain post-closing adjustments.
- Additional shares may be issued if Honey Birdette exceeds specified 2021 or 2022 financial targets. Conversely, a portion of the stock consideration may be canceled if specified results are not achieved.
- PLBY must file a Form S-1 registration statement covering shares issued as consideration, including any shares issued under the True-Up provisions.
Debt, Liquidity, and Capital Structure
- PLBY obtained a $70 million incremental term loan, increasing aggregate term-loan borrowings to $230 million.
- The incremental borrowing, together with cash on hand, financed the acquisition and related fees and expenses.
- The aggregate term loan matures on May 25, 2027.
- The stated effective rate is generally LIBOR plus 5.75%, with a 0.50% LIBOR floor. Applicable margins may vary based on the total leverage ratio and borrowing type.
- Quarterly amortization of 1.00% per annum begins September 30, 2021.
- Honey Birdette and certain subsidiaries became guarantors under the amended credit agreement.
- The filing does not provide post-transaction cash balances, liquidity measures, revenue, profit, operating margins, or cash-flow data.
Material Changes and Corporate Governance
- The acquisition materially expanded PLBY’s operations into Honey Birdette’s business and increased term-loan indebtedness by $70 million.
- Dr. Suying Liu resigned from PLBY’s Board effective August 9, 2021. The filing states the resignation was not due to disagreement with PLBY.
- Following the resignation, PLBY temporarily did not satisfy Nasdaq requirements for a majority-independent Board and a three-member independent Audit Committee.
- PLBY notified Nasdaq and stated that it intended to use the applicable cure periods to appoint a replacement independent director.
Outlook, Contingencies, and Unusual Items
- The transaction includes contingent True-Up provisions tied to Honey Birdette’s 2021 and 2022 financial performance.
- Final consideration may change through post-closing adjustments, escrow claims, additional share issuances, or cancellation of a portion of the stock consideration.
- The filing does not provide formal earnings guidance or quantified post-acquisition synergies.
- Honey Birdette’s required historical financial statements and pro forma financial information were to be filed by amendment within 71 calendar days after the applicable Form 8-K filing deadline; they are not included in the provided text.
- The filing contains a date inconsistency: the acquisition closing is identified as August 9, while the credit agreement amendment is dated August 11.
Important Facts for Investors to Verify
- Review the subsequently filed Honey Birdette historical financial statements and pro forma financial information.
- Confirm the final purchase price, exchange-rate effects, escrow releases, and any post-closing True-Up adjustments.
- Monitor the number and registration status of shares issued to the sellers and any additional shares issued or canceled.
- Assess PLBY’s post-acquisition leverage, interest expense, amortization obligations, and compliance with credit agreement covenants.
- Confirm the appointment of an independent director and restoration of compliance with Nasdaq Board and Audit Committee requirements.